Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gates

Showing results (301-310 of 324) with videos related to

Pageof 33
Sort By:
Journal of the American College of Surgeons|February 21, 2009
Longterm followup assessment of a HER2/neu peptide (E75) vaccine for prevention of recurrence in high-risk prostate cancer patientsJeremy D Gates, Mark G Carmichael, Linda C Benavides, et al.
Advances in Marine Biology|August 11, 2012
Molecular delineation of species in the coral holobiontMichael Stat, Andrew C Baker, David G Bourne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccineJarrod P Holmes, Linda C Benavides, Jeremy D Gates, et al.
Ecological Applications : a Publication of the Ecological Society of America|May 11, 2022
Scale dependence of coral reef oases and their environmental correlatesRobin Elahi, Peter J Edmunds, Ruth D Gates, et al.
The Review of Scientific Instruments|September 4, 2012
Layout and results from the initial operation of the high-resolution x-ray imaging crystal spectrometer on the Large Helical DeviceN A Pablant, M Bitter, L Delgado-Aparicio, et al.
Cancer Immunology, Immunotherapy : CII|April 9, 2008
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02Asna Amin, Linda C Benavides, Jarrod P Holmes, et al.
Trauma Surgery & Acute Care Open|June 25, 2026
Workplace violence in trauma centers is a serious problem: an AAST Disaster Committee survey on assaults on trauma teamsAmy E Liepert, Mary E Fallat, Jeannette M Capella, et al.
The ISME Journal|April 18, 2015
The coral core microbiome identifies rare bacterial taxa as ubiquitous endosymbiontsTracy D Ainsworth, Lutz Krause, Thomas Bridge, et al.
Vaccine|September 23, 2010
Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptideJeremy D Gates, Guy T Clifton, Linda C Benavides, et al.
Toxicologic Pathology|January 7, 2016
Drug-induced Liver Fibrosis: Testing Nevirapine in a Viral-like Liver Setting Using Histopathology, MALDI IMS, and Gene ExpressionH Roger Brown, Stephen Castellino, M Reid Groseclose, et al.
Pageof 33

Showing results (301-310 of 324) with videos related to

Sort By:
Pageof 33
Journal of the American College of Surgeons|February 21, 2009
Longterm followup assessment of a HER2/neu peptide (E75) vaccine for prevention of recurrence in high-risk prostate cancer patientsJeremy D Gates, Mark G Carmichael, Linda C Benavides, et al.
Advances in Marine Biology|August 11, 2012
Molecular delineation of species in the coral holobiontMichael Stat, Andrew C Baker, David G Bourne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccineJarrod P Holmes, Linda C Benavides, Jeremy D Gates, et al.
Ecological Applications : a Publication of the Ecological Society of America|May 11, 2022
Scale dependence of coral reef oases and their environmental correlatesRobin Elahi, Peter J Edmunds, Ruth D Gates, et al.
The Review of Scientific Instruments|September 4, 2012
Layout and results from the initial operation of the high-resolution x-ray imaging crystal spectrometer on the Large Helical DeviceN A Pablant, M Bitter, L Delgado-Aparicio, et al.
Cancer Immunology, Immunotherapy : CII|April 9, 2008
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02Asna Amin, Linda C Benavides, Jarrod P Holmes, et al.
Trauma Surgery & Acute Care Open|June 25, 2026
Workplace violence in trauma centers is a serious problem: an AAST Disaster Committee survey on assaults on trauma teamsAmy E Liepert, Mary E Fallat, Jeannette M Capella, et al.
The ISME Journal|April 18, 2015
The coral core microbiome identifies rare bacterial taxa as ubiquitous endosymbiontsTracy D Ainsworth, Lutz Krause, Thomas Bridge, et al.
Vaccine|September 23, 2010
Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptideJeremy D Gates, Guy T Clifton, Linda C Benavides, et al.
Toxicologic Pathology|January 7, 2016
Drug-induced Liver Fibrosis: Testing Nevirapine in a Viral-like Liver Setting Using Histopathology, MALDI IMS, and Gene ExpressionH Roger Brown, Stephen Castellino, M Reid Groseclose, et al.
Pageof 33